Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    ALX4
Show Display Options
Rank Status Study
1 Recruiting Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population
Conditions: Colorectal Neoplasms;   Adenoma;   Colorectal Tumors
2 Terminated First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4
Condition: Healthy Volunteers
Interventions: Biological: ALX-0651;   Biological: Placebo
3 Completed TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
4 Completed Open Label Extension Study of PREOS
Condition: Osteoporosis
Intervention: Drug: ALX1-11 (drug)
5 Completed A Double Blind, Placebo Controlled, Parallel-Group Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: ALX1-11
6 Recruiting The Severe Asthma Research Program III-Boston Clinical Site
Condition: Asthma
7 Completed Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: ALX-0061;   Biological: Placebo
8 Unknown  Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: ALX-0600
9 Completed Effect of Teduglutide on Gastric Emptying in Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Placebo;   Drug: teduglutide
10 Not yet recruiting A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: ALX-0061;   Biological: Placebo;   Biological: Tocilizumab
11 Completed Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
Conditions: Unstable Angina;   Non ST Segment Elevation Myocardial Infarction (NSTEMI);   Stable Angina (Associated With High Risk PCI)
Interventions: Drug: ALX-0081;   Drug: ReoPro®
12 Completed ALX-0171 Safety Study in Adults With Hyperresponsive Airways
Condition: Respiratory Syncytial Virus Infection
Intervention: Biological: ALX-0171
13 Completed
Has Results
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Condition: Short Bowel Syndrome
Interventions: Drug: teduglutide;   Drug: placebo
14 Completed Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Conditions: Laparoscopic Gynecologic, Abdominal, Other Surgery;   General Anesthesia
Interventions: Drug: Palonosetron;   Drug: placebo control group

Indicates status has not been verified in more than two years